Diabetes drug trial aims to curb drinking and smoking in HIV patients
NCT ID NCT07221214
Summary
This study is testing whether the medication semaglutide can help adults living with HIV drink less alcohol and smoke fewer cigarettes. Researchers want to see if reducing these habits also lowers the risk of heart disease in this population. About 200 participants will take either semaglutide or a placebo for three months while having regular checkups and providing samples for testing.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.